Contact

Please use this form to send email to PR contact of this press release:
Immunomic Therapeutics Announces Data Analysis of Phase IB Study to Treat Japanese Red Cedar Allergy

TO:
Dr. Bill Hearl
Immunomic Therapeutics, Inc
717-327-1919

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.